Reactive oxygen species and oxidative stress

Contributions to Nephrology

Volumn 170, Issue , 2011, Pages 102-112

  Noh, Hyunjin ^a   Ha, Hunjoo ^b  

^a Soonchunhyang University   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

NFE2L2 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2;

ANIMAL; ARTICLE; DIABETIC NEPHROPATHY; HUMAN; METABOLISM; MITOCHONDRION; OXIDATIVE STRESS; PHYSIOLOGY;

ANIMALS; DIABETIC NEPHROPATHIES; HUMANS; MITOCHONDRIA; NADPH OXIDASE; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84875790877     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000324955     Document Type: Article

References (43)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003;108: 2154-2169. (Pubitemid 37337595)
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
3. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
4. Forbes JM, Coughlan MT, Cooper ME: Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008;57:1446-1454.
5. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820. (Pubitemid 34000785)
6. Kakehi T, Yabe-Nishimura C: NOX enzymes and diabetic complications. Semin Immunopathol 2008;30:301-314.
7. Finkel T, Holbrook NJ: Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408:239-247.
8. Sies H: Oxidative stress: From basic research to clinical application. Am J Med 1991;91:31S-38S.
9. Lenaz G, Bovina C, D'Aurelio M, Fato R, Formiggini G, Genova ML, Giuliano G, Pich MM, Paolucci UGO, Castelli GP, Ventura B: Role of mitochondria in oxidative stress and aging. Ann N Y Acad Sci 2002;959:199-213. (Pubitemid 34457563)
10. Ha H, Hwang IA, Park JH, Lee HB: Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res Clin Pract 2008;82:S42-S45.
11. Rhee S, Chang T-S, Jeong W, Kang D: Methods for detection and measurement of hydrogen peroxide inside and outside of cells. Mol Cells 2010;29:539-549.
12. Ha H, Lee HB: Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int Suppl 2000;77:S19-S25.
13. Ha H, Kim C, Son Y, Chung MH, Kim KH: DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radic Biol Med 1994;16:271-274. (Pubitemid 24117509)
14. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, Haneda M: Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 2003;14:S250-S253. (Pubitemid 36903935)
15. Lee EA, Seo JY, Jiang Z, Yu MR, Kwon MK, Ha H, Lee HB: Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney. Kidney Int 2005;67:1762-1771. (Pubitemid 40577711)
16. Brezniceanu ML, Liu F, Wei CC, Tran S, Sachetelli S, Zhang SL, Guo DF, Filep JG, Ingelfinger JR, Chan JSD: Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int 2007;71:912-923. (Pubitemid 46663797)
17. Prabhakar S, Starnes J, Shi S, Lonis B, Tran R: Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production. J Am Soc Nephrol 2007; 18:2945-2952. (Pubitemid 350058402)
18. Chiarelli F, Cipollone F, Mohn A, Marini M, Iezzi A, Fazia M, Tumini S, De Cesare D, Pomilio M, Pierdomenico SD, Di Gioacchino M, Cuccurullo F, Mezzetti A: Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes. Diabetes Care 2002;25:1829-1834. (Pubitemid 41071095)
19. Calabrese V, Mancuso C, Sapienza M, Puleo E, Calafato S, Cornelius C, Finocchiaro M, Mangiameli A, Di Mauro M, Stella AMG, Castellino P: Oxidative stress and cellular stress response in diabetic nephropathy. Cell Stress Chaperones 2007;12:299-306.
20. Martín-Hernández E, García-Silva MT, Vara J, Campos Y, Cabello A, Muley R, del Hoyo P, Martín MA, Arenas J: Renal pathology in children with mitochondrial diseases. Pediatr Nephrol 2005;20:1299-1305. (Pubitemid 41226421)
21. Diomedi-Camassei F, Di Giandomenico S, Santorelli FM, Caridi G, Piemonte F, Montini G, Ghiggeri GM, Murer L, Barisoni L, Pastore A, Muda AO, Valente ML, Bertini E, Emma F: COQ2 nephropathy: A newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol 2007;18:2773-2780. (Pubitemid 47531205)
22. Coughlan MT, Thorburn DR, Penfold SA, Laskowski A, Harcourt BE, Sourris KC, Tan ALY, Fukami K, Thallas-Bonke V, Nawroth PP, Brownlee M, Bierhaus A, Cooper ME, Forbes JM: RAGE-Induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J Am Soc Nephrol 2009;20: 742-752.
23. Lassegue B, Griendling KK: NADPH oxidases: Functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 2010;30:653-661.
24. Kashihara N, Haruna Y, Kondeti VK, Kanwar YS: Oxidative stress in diabetic nephropathy. Curr Med Chem 2010;17:4256-4269.
25. Gao L, Mann GE: Vascular NAD(P)H oxidase activation in diabetes: A double-edged sword in redox signalling. Cardiovasc Res 2009;82:9-20.
26. Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, Lee HB: Role of reactive oxygen species in TGF-ß1-induced mitogen-activated protein kinase activation and epithelialmesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 2005;16: 667-675. (Pubitemid 41725103)
27. Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, Wilcox CS: Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 2005;67:1890-1898. (Pubitemid 40577724)
28. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL, Abboud HE: Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 2005;280:39616-39626. (Pubitemid 41713921)
29. Li W-G, Miller FJ, Zhang HJ, Spitz DR, Oberley LW, Weintraub NL: H2O2-induced O2 production by a non-phagocytic NAD(P) H oxidase causes oxidant injury. J Biol Chem 2001;276:29251-29256.
30. Ceriello A, Morocutti A, Mercuri F, Quagliaro L, Moro M, Damante G, Viberti GC: Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 2000;49: 2170-2177.
31. Frederick RD, Patricia AC, Mona FM: Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: Effects of tempol. Metabolism 2007;56: 1256-1264.
32. Möllsten A, Marklund SL, Wessman M, Svensson M, Forsblom C, Parkkonen M, Brismar K, Groop P-H, Dahlquist G: A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes 2007;56:265-269.
33. Chander PN, Gealekman O, Brodsky SV, Elitok S, Tojo A, Crabtree M, Gross SS, Goligorsky MS: Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: Prevention by chronic therapy with a peroxynitrite scavenger ebselen. J Am Soc Nephrol 2004;15:2391-2403. (Pubitemid 39159339)
34. Brezniceanu M-L, Liu F, Wei C-C, Chénier I, Godin N, Zhang S-L, Filep JG, Ingelfinger JR, Chan JSD: Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes 2008;57:451-459.
35. de Haan JB, Stefanovic N, Nikolic-Paterson D, Scurr LL, Croft KD, Mori TA, Hertzog P, Kola I, Atkins RC, Tesch GH: Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy. Am J Physiol Renal Physiol 2005;289:F544-F551. (Pubitemid 41208469)
36. Abraham NG, Kappas A: Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 2005;39:1-25. (Pubitemid 40733115)
37. Di Noia MA, Van Driesche S, Palmieri F, Yang L-M, Quan S, Goodman AI, Abraham NG: Heme oxygenase-1 enhances renal mitochondrial transport carriers and cytochrome c oxidase activity in experimental diabetes. J Biol Chem 2006;281:15687-15693. (Pubitemid 43848455)
38. Zhang DD: Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 2006;38:769-789. (Pubitemid 44903268)
39. Jiang T, Huang Z, Lin Y, Zhang Z, Fang D, Zhang DD: The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes 2010;59:850-860.
40. Craven PA, Melhem MF, Phillips SL, DeRubertis FR: Overexpression of Cu2+/ Zn2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes 2001;50:2114-2125. (Pubitemid 33643680)
41. Hamada Y, Miyata S, Nii-Kono T, Kitazawa R, Kitazawa S, Higo S, Fukunaga M, Ueyama S, Nakamura H, Yodoi J, Fukagawa M, Kasuga M: Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy. Nephrol Dial Transplant 2007;22:1547-1557. (Pubitemid 47073752)
42. Karachalias N, Babaei-Jadidi R, Rabbani N, Thornalley P: Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes. Diabetologia 2010;53:1506-1516.
43. Alkhalaf A, Klooster A, van Oeveren W, Achenbach U, Kleefstra N, Slingerland RJ, Mijnhout GS, Bilo HJG, Gans ROB, Navis GJ, Bakker SJL: A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy. Diabetes Care 2010;33: 1598-1601.